Gene Therapy Project
A project driven by one family’s story and a shared belief that rare diseases deserve real solutions.
Where it all began
Where it all began
The development of gene therapy for GAND did not begin in a laboratory or a boardroom. It began in the life of one family, with the realization that for a rare genetic condition like GAND, there is currently no treatment that addresses its cause.
Existing therapies can support development and improve quality of life, but they cannot stop the disease itself. This realization was difficult, but it also became the driving force to take action.
From the desire to create hope, a future, and real possibilities for Lora and other children with this condition, the idea for this project was born.
What makes this project different
This project is deeply personal. It is built around real children, real families, and real stories.
It represents a collaboration between science and determination — between experts and families who are not willing to accept that rarity is a reason to stop searching for solutions.
Many rare diseases remain without treatment because research is complex, time-consuming, and financially risky. This is why the support of the community, donors, and partners is essential, not only financially, but as a statement that every child matters.
The goal of gene therapy
The goal of this project is to address the root cause of GAND, a malfunction in the gene responsible for the condition.
The hope is that gene therapy could improve development, enhance quality of life, and open new possibilities for the future.
The path is long and complex, but every step forward represents progress. This project is not only a scientific challenge, but a story of persistence, collaboration, and belief in change.